Lessons from how bats resist covid could inform new treatments in humans miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Noxopharm Ltd (ASX:NOX) is set for a very busy six months ahead with news flow expected from its Veyonda® immune-oncology drug that works with the body’s defence mechanisms to fight cancer cells.
The clinical-stage drug development company is targeting Veyonda® to become a standard go-to drug to boost the effectiveness of a range of anti-cancer therapies such as radiation treatment and chemotherapy.
It has an exciting pipeline of drugs under development and believes that its novel technology platform is “one of the most exciting and valuable platforms” in the pharmaceutical industry.
News flow ahead
Noxopharm chief executive officer Graham Kelly said the company was into some of the latest and most active areas of interest by the pharmaceutical industry - areas spanning cancer, chronic inflammatory diseases and autoimmune disorders.
Science & Technology Australia welcomes new committee members miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Hudson Institute
Hudson Institute of Medical Research scientist Dr Erin McGillick has received the national QueersInScience Scott Johnson Memorial Award for contribution to LGBTIQA+ advocacy in STEM.
L-R: Dr Erin McGillick pictured with Co-founder and Director of QueersInScience, Dr Sarah Stephenson
Dr McGillick was recognised for her LGBTIQA+ advocacy work in 2020 at the institutional and national level.
As a member of the Equity and Diversity Committee at Hudson Institute, Dr McGillick has focused on growing the Institute’s LGBT+ STEM focused initiatives.
Together with Dr Beth Allison they have established the Hudson Institute Ally Network and hosted celebrations for LGBT+ STEM Day. She is also a member of the Monash Ally Network.
Hudson Institute
Hudson Institute PhD graduate Dr Aidan Kashyap has received one of Monash University’s highest student academic honors for his research into congenital diaphragmatic hernia (CDH).
Dr Aidan Kashyap
Dr Kashyap received the Mollie Holman Medal for his research, marking him as a researcher of the highest order, receiving the best thesis of the year for the faculty of medicine, nursing and health sciences.
Most babies navigate the transition to newborn life without complications, however some require assistance in breathing at birth because their underdeveloped lungs are not ready for life in the outside world. One devastating cause of impaired lung development is CDH.